MARIE ROHRER: Open Payments
NPI 1699309377 · DAVENPORT, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 16 payments from 9 companies in 2025. Trend: 2023 $954 · 2024 $455 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $146 |
| Lilly USA, LLC | 2 | $102 |
| Novo Nordisk Inc | 2 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| Abbott Laboratories | 1 | $25 |
| Exact Sciences Corporation | 1 | $24 |
| ABBVIE INC. | 1 | $18 |
| PFIZER INC. | 1 | $18 |
Products named: AIRSUPRA, KISUNLA, Ozempic, JARDIANCE, VOQUEZNA, FREESTYLE LIBRE 3, Cologuard Collection Kit, FARXIGA.
Industry payments across IA — which companies pay providers there.
